Friday, July 10, 2026

Drug profile · INN

govorestat

govorestat (NUGALVIQ) is an FDA-listed pharmaceutical active ingredient.

EMA: application withdrawn Alimentary tract and metabolism (A16) A16AX24
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — govorestat
Class
Alimentary tract and metabolism (A16)
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

govorestat (NUGALVIQ) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN govorestat
Brand NUGALVIQ
Therapeutic class Alimentary tract and metabolism (A16)
ATC code A16AX24

Approval history

Authority Status Date
EMA application withdrawn

Related & competitor drugs

  1. agalsidase alfa Alimentary tract and metabolism (A16)
  2. alogliptin Alimentary tract and metabolism (A10)
  3. alogliptin benzoate Alimentary tract and metabolism (A10)
  4. aprepitant Alimentary tract and metabolism (A04)
  5. budesonide Alimentary tract and metabolism (A07)
  6. canagliflozin Alimentary tract and metabolism (A10)

Frequently asked questions

What is govorestat?

govorestat (NUGALVIQ) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for govorestat?

NUGALVIQ is a marketed brand name for govorestat. Check FDA Drugs@FDA for the current US label holder and prescribing information.